Article

Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment…

Patient Preference and Adherence · 2023 · Tanaka Y, Genovese MC, Matsushima H

Key facts

Title Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives
First author Tanaka Y, Genovese MC, Matsushima H
Journal Patient Preference and Adherence
Published Oct 6, 2023
DOI 10.2147/PPA.S417677
Devices mentioned 200493, 210105, 210457, 212595, K831245, K852441, K854177, K854178, K854179, K854180, K854181, K854182 and 6 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DXN, KLB and 2 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature